Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. [clinicaltrials:NCT00051103]
Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. [clinicaltrials:NCT00051103]
Bio2RDF identifier
NCT00051103
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00051103
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... nown to overexpress HER2/neu.
brief title [clinicaltrials_vocabulary:brief-title]
Oral Drug Study In Women With ...... line or Second-line Herceptin.
completion date [clinicaltrials_vocabulary:completion-date]
2005-06-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2003-01-03T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Refractory
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-04-14T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00051103
official title [clinicaltrials_vocabulary:official-title]
An Open-Label, Multicenter, Si ...... Herceptin Containing Regimens
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2005-06-01T00:00:00Z
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-10-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-04-01T00:00:00Z
identifier
clinicaltrials:NCT00051103
title
Oral Drug Study In Women With ...... line or Second-line Herceptin.
@en
type
label
Oral Drug Study In Women With ...... . [clinicaltrials:NCT00051103]
@en